blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2948134

EP2948134 - COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS [Right-click to bookmark this link]
Former [2015/49]COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
[2019/16]
StatusNo opposition filed within time limit
Status updated on  08.01.2021
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  31.01.2020
FormerGrant of patent is intended
Status updated on  17.09.2019
FormerExamination is in progress
Status updated on  31.08.2019
FormerGrant of patent is intended
Status updated on  22.04.2019
FormerExamination is in progress
Status updated on  16.02.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Palvella Therapeutics, Inc.
125 Strafford Avenue
Suite 360
Wayne, Pennsylvania 19087 / US
[2019/17]
Former [2019/16]For all designated states
Palvella Therapeutics LLC
515 Red Fox Lane, Suite B
Wayne, PA 19087 / US
Former [2015/49]For all designated states
Transderm, Inc.
2386 East Heritage Way
Salt Lake City, UT 84109 / US
Inventor(s)01 / KASPAR, Roger L.
218 Sheldon Avenue
Santa Cruz, California 95060 / US
02 / SPEAKER, Tycho
824 Western Drive
Santa Cruz, California 95060 / US
 [2015/49]
Representative(s)Lahrtz, Fritz, et al
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
[2020/10]
Former [2015/49]Lahrtz, Fritz
Isenbruck Bösl Hörschler LLP
Patentanwälte
Prinzregentenstraße 68
81675 München / DE
Application number, filing date14743123.324.01.2014
[2015/49]
WO2014US13066
Priority number, dateUS201361756406P24.01.2013         Original published format: US 201361756406 P
[2015/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014117035
Date:31.07.2014
Language:EN
[2014/31]
Type: A1 Application with search report 
No.:EP2948134
Date:02.12.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2014 takes the place of the publication of the European patent application.
[2015/49]
Type: B1 Patent specification 
No.:EP2948134
Date:04.03.2020
Language:EN
[2020/10]
Search report(s)International search report - published on:US31.07.2014
(Supplementary) European search report - dispatched on:EP27.07.2016
ClassificationIPC:A61K9/70, A61K31/436, C07D491/00
[2015/49]
CPC:
A61K9/0014 (EP,US); A61K31/436 (EP,US); A61K47/10 (EP,US);
A61K47/12 (EP,US); A61K47/32 (EP,US); C07D498/18 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN ZUR TRANSDERMALEN VERABREICHUNG VON MTOR-INHIBITOREN[2015/49]
English:COMPOSITIONS FOR TRANSDERMAL DELIVERY OF MTOR INHIBITORS[2019/16]
French:COMPOSITIONS POUR UNE ADMINISTRATION TRANSDERMIQUE D'INHIBITEURS DE MTOR[2015/49]
Former [2015/49]COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
Entry into regional phase21.08.2015National basic fee paid 
21.08.2015Search fee paid 
21.08.2015Designation fee(s) paid 
21.08.2015Examination fee paid 
Examination procedure21.08.2015Examination requested  [2015/49]
22.02.2017Amendment by applicant (claims and/or description)
20.02.2018Despatch of a communication from the examining division (Time limit: M04)
29.06.2018Reply to a communication from the examining division
23.04.2019Communication of intention to grant the patent
29.08.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.09.2019Communication of intention to grant the patent
14.01.2020Fee for grant paid
14.01.2020Fee for publishing/printing paid
14.01.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.02.2018
Opposition(s)07.12.2020No opposition filed within time limit [2021/06]
Fees paidRenewal fee
27.01.2016Renewal fee patent year 03
27.01.2017Renewal fee patent year 04
29.01.2018Renewal fee patent year 05
28.01.2019Renewal fee patent year 06
27.01.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.01.2014
AT04.03.2020
CY04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
MK04.03.2020
MT04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
TR04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
[2024/41]
Former [2024/29]HU24.01.2014
AT04.03.2020
CY04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
MK04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
TR04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2024/22]HU24.01.2014
AT04.03.2020
CY04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
MK04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2023/30]HU24.01.2014
AT04.03.2020
CY04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2023/27]HU24.01.2014
AT04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2021/40]AT04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2021/11]AT04.03.2020
CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
NL04.03.2020
PL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2020/50]CZ04.03.2020
EE04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
NL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2020/49]CZ04.03.2020
FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
NL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2020/48]FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
NL04.03.2020
RO04.03.2020
RS04.03.2020
SE04.03.2020
SM04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
PT29.07.2020
Former [2020/47]FI04.03.2020
HR04.03.2020
LT04.03.2020
LV04.03.2020
NL04.03.2020
RS04.03.2020
SE04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/46]FI04.03.2020
HR04.03.2020
LV04.03.2020
NL04.03.2020
RS04.03.2020
SE04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/45]FI04.03.2020
HR04.03.2020
LV04.03.2020
NL04.03.2020
RS04.03.2020
SE04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
Former [2020/39]FI04.03.2020
HR04.03.2020
LV04.03.2020
RS04.03.2020
SE04.03.2020
BG04.06.2020
NO04.06.2020
GR05.06.2020
Former [2020/38]FI04.03.2020
HR04.03.2020
LV04.03.2020
RS04.03.2020
SE04.03.2020
NO04.06.2020
GR05.06.2020
Former [2020/37]FI04.03.2020
HR04.03.2020
LV04.03.2020
RS04.03.2020
SE04.03.2020
NO04.06.2020
Former [2020/35]FI04.03.2020
NO04.06.2020
Documents cited:Search[I]US2001031769  (JACKMAN MARTIN [CH], et al) [I] 1-15 * paragraph [0001] - paragraph [0010] * * paragraph [0029] - paragraph [0110]; examples 1, 2 * * paragraph [0125] - paragraph [0127]; examples 17-19 * * paragraph [0137]; examples 26, 27 * * claims 1-10 *;
 [I]US2005250804  (KANNAN MUTHAIYYAN ESAKKI [IN], et al) [I] 1-15 * paragraph [0002] - paragraph [0024] * * paragraph [0037] - paragraph [0051] ** example 1; claims 1-21; table 1 *
International search[Y]US6958153  (ORMEROD ANTHONY DAVID [GB], et al);
 [X]US2009130029  (TAMARKIN DOV [IL], et al);
 [A]US2012022095  (TENG JOYCE M C [US], et al);
 [Y]US8114385  (TAMARKIN DOV [IL], et al);
 [A]CA2825786  (UNIV OSAKA [JP])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.